Literature DB >> 2575914

Do negative symptoms respond to pharmacological treatment?

J M Kane1, D Mayerhoff.   

Abstract

Mesh：

Substances：

Year:  1989        PMID： 2575914

Source DB:  PubMed          Journal:  Br J Psychiatry Suppl        ISSN： 0960-5371


× No keyword cloud information.
  8 in total

Review 1.  Novel antipsychotics: issues and controversies. Typicality of atypical antipsychotics.

Authors:  E Stip
Journal:  J Psychiatry Neurosci       Date:  2000-03       Impact factor: 6.186

Review 2.  Amisulpride: a review of its use in the management of schizophrenia.

Authors:  M P Curran; C M Perry
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 3.  A risk-benefit assessment of sulpiride in the treatment of schizophrenia.

Authors:  M C Mauri; S Bravin; A Bitetto; R Rudelli; G Invernizzi
Journal:  Drug Saf       Date:  1996-05       Impact factor: 5.606

4.  Olanzapine in the treatment of schizophrenia : an open label comparative clinical trial from north India.

Authors:  A Avasthi; P Kulhara; N Kakkar
Journal:  Indian J Psychiatry       Date:  2001-07       Impact factor: 1.759

Review 5.  Negative symptoms in schizophrenia: considerations for clinical trials. Working group on negative symptoms in schizophrenia.

Authors:  H J Möller; H M van Praag; B Aufdembrinke; P Bailey; T R Barnes; J Beck; H Bentsen; F X Eich; L Farrow; W W Fleischhacker
Journal:  Psychopharmacology (Berl)       Date:  1994-06       Impact factor: 4.530

6.  Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors.

Authors:  R Corbett; F Camacho; A T Woods; L L Kerman; R J Fishkin; K Brooks; R W Dunn
Journal:  Psychopharmacology (Berl)       Date:  1995-07       Impact factor: 4.530

7.  Mutual activation of glutamatergic mGlu4 and muscarinic M4 receptors reverses schizophrenia-related changes in rodents.

Authors:  Paulina Cieślik; Monika Woźniak; Jerri M Rook; Mohammed N Tantawy; P Jeffrey Conn; Francine Acher; Krzysztof Tokarski; Magdalena Kusek; Andrzej Pilc; Joanna M Wierońska
Journal:  Psychopharmacology (Berl)       Date:  2018-07-27       Impact factor: 4.530

Review 8.  Long-acting antipsychotic drugs for the treatment of schizophrenia: use in daily practice from naturalistic observations.

Authors:  Giuseppe Rossi; Sonia Frediani; Roberta Rossi; Andrea Rossi
Journal:  BMC Psychiatry       Date:  2012-08-21       Impact factor: 3.630
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.